Ictero
Freezing gallstone disease in its tracks
Texas, United States · Founded 2018 · $6.0M raised
- Headquarters
- Texas
- Founded
- 2018
- Business Model
- B2B
- Total Funding
- $6.0M
- Last Round
- $6.0M Series AApr 2022
- Rounds
- 1
About
Ictero Medical develops a minimally invasive, catheter-based cryoablation system that treats gallstone disease without surgically removing the gallbladder. Born out of the Texas Medical Center Biodesign fellowship, the company built The CholeSafe System as a definitive treatment delivered in the interventional radiology suite, giving high-risk patients the benefits of surgery without the operative risk. The team of engineers, clinicians, and entrepreneurs is advancing the technology through product development and clinical testing.
Summary
Ictero is a Biotech company based in Texas, United States, founded in 2018. It has raised $6.0M in total across 1 round, most recently a $6.0M Series A round in Apr 2022. Investors include MedTex Ventures and S3 Ventures.
Funding History
Apr 2022
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ictero"><img src="https://indexed.vc/api/badge/company/ictero" alt="Ictero on Indexed.vc" width="260" height="76" /></a>